Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
ranibizumab (lucentis) (1 trial)
jy09 (2 trials)
Diabetes Mellitus, Type 2 (Phase 1)
Trials (3 total)
Trial APIs (2 total)